Predictions
Nanodimension Ltd. ADR
Start price
Target price
Perf. (%)
€3.94
20.10.20
20.10.20
-
04.11.21
04.11.21
31.98%
05.11.21
05.11.21
High valuation
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Match Group Inc old
Start price
Target price
Perf. (%)
€94.85
20.10.20
20.10.20
€100.00
04.11.20
04.11.20
-
04.11.20
04.11.20
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Strong uniques
AMC Entertainment Holdings Inc.
Start price
Target price
Perf. (%)
€3.02
19.10.20
19.10.20
€1.00
31.10.20
31.10.20
-33.77%
31.10.20
31.10.20
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
Farfetch Ltd
Start price
Target price
Perf. (%)
€23.40
19.10.20
19.10.20
€27.00
31.10.20
31.10.20
4.27%
31.10.20
31.10.20
Top 10 in its market
Known brand
Probably not worthwhile Investment
Low dividend yield expected
Apple Inc.
Start price
Target price
Perf. (%)
€100.68
19.10.20
19.10.20
€90.00
04.11.21
04.11.21
-0.08%
11.11.20
11.11.20
Known brand
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Allianz SE VNA
Start price
Target price
Perf. (%)
€164.18
19.10.20
19.10.20
€240.00
04.11.21
04.11.21
22.70%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Very high dividend yield expected
Top Rating
Very capable Management
BIMI International Medical Inc
Start price
Target price
Perf. (%)
€10.50
19.10.20
19.10.20
€5.00
04.11.21
04.11.21
-70.48%
05.11.21
05.11.21
Risky Investment
Apple Inc.
Start price
Target price
Perf. (%)
€101.86
19.10.20
19.10.20
-
04.11.21
04.11.21
7.11%
20.06.21
20.06.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Capable Management
Apple Inc.
Start price
Target price
Perf. (%)
€101.86
19.10.20
19.10.20
-
04.11.21
04.11.21
29.12%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Very capable Management
Very good company culture
Market Leader or Top 3
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
€4.00
30.10.20
30.10.20
14.26%
30.10.20
30.10.20
Probably not worthwhile Investment
Jumia Technologies AG
Start price
Target price
Perf. (%)
€12.80
19.10.20
19.10.20
-
04.11.21
04.11.21
24.22%
05.11.21
05.11.21
EBIT growth >5% per year expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
-
04.11.21
04.11.21
-72.31%
05.11.21
05.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Yum! Brands Inc.
Start price
Target price
Perf. (%)
€84.33
19.10.20
19.10.20
-
04.11.21
04.11.21
4.54%
26.12.20
26.12.20
Probably not worthwhile Investment
Revenue decline/stagnation expected
Increased challenges to pay loans and raise capital
Genmark Diagnostics
Start price
Target price
Perf. (%)
€9.65
19.10.20
19.10.20
€12.00
02.11.20
02.11.20
12.95%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€12.20
19.10.20
19.10.20
€15.00
02.11.20
02.11.20
-6.56%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€16.30
19.10.20
19.10.20
€20.00
02.11.20
02.11.20
-0.61%
02.11.20
02.11.20
Could be very worthwhile Investment >20% year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
19.10.20
19.10.20
€10.00
02.11.20
02.11.20
-
02.11.20
02.11.20
Could be very worthwhile Investment >20% year
Epigenomics AG NA
Start price
Target price
Perf. (%)
€0.51
18.10.20
18.10.20
€1.00
02.11.20
02.11.20
20.00%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Innovative
Maxeon Solar Technologies Ltd.
Start price
Target price
Perf. (%)
€14.30
18.10.20
18.10.20
€7.00
04.11.21
04.11.21
21.33%
26.06.21
26.06.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
GNI Group Ltd
Start price
Target price
Perf. (%)
€24.00
18.10.20
18.10.20
€12.00
04.11.21
04.11.21
-35.42%
26.06.21
26.06.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
Below average Management
Little innovation
EAC Invest A/S
Start price
Target price
Perf. (%)
€645.30
18.10.20
18.10.20
€300.00
04.11.21
04.11.21
129.35%
26.06.21
26.06.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€5.70
18.10.20
18.10.20
€2.00
04.11.21
04.11.21
-35.79%
26.06.21
26.06.21
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation